Wealthcare Advisory Partners LLC Sells 521 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Wealthcare Advisory Partners LLC lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 4.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,540 shares of the financial services provider’s stock after selling 521 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,394,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. BNP Paribas Financial Markets lifted its position in shares of iShares Biotechnology ETF by 29.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after buying an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in shares of iShares Biotechnology ETF by 32.9% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after acquiring an additional 164,000 shares during the period. Aprio Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at $18,476,000. Aristides Capital LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth about $9,180,000. Finally, Sanctuary Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth about $8,118,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $132.65 on Friday. The company’s 50-day moving average price is $136.62 and its two-hundred day moving average price is $141.81. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.